Given that 1 in 10 adults are misusing drugs, the U.S. Preventive Services Task Force (USPSTF) is recommending that primary care providers screen all adult patients for Substance Use Disorders.
Of the 30 screening tools USPSTF reviewed, none of them have shown benefit or harm to patients. Surprisingly and sadly, the tools had only 1-2 studies, limiting their reliability. Why has the healthcare community accepted tools that are insufficiently validated? Isn’t it pretty obvious that stigma is at work here?
Why bother using any screening tools if they don’t make a difference in treatment outcomes? Perhaps because up until now, there haven’t been better options.
After three years in research and development, McRISC© has completed 3 internal validation studies, and includes evidence-based risk factors that no other tool captures. It already significantly improves upon the current “gold standard” tools used:
Predicts addiction risk to help prevent it
Offers acute and chronic illness diagnostics (intervals from 7 days to over 12-months)
Separates diagnostics among alcohol, illicit drugs, prescription drugs, and nicotine use
Assesses the latest adolescent healthcare epidemic, vaping, alongside tobacco
Takes 10 minutes, is comprehensive, online, and accessible to all
We believe in a longer life-saving view; people suffering from Substance Use Disorders deserve to achieve the targeted treatments and lasting remissions routinely established for other chronic illnesses.
Let’s end the stigma!
Thank you for listening.
Joyce and Calvin